… To evaluate overall survival and locoregional recurrence … and sentinel node metastasis
undergoing sentinel lymph node … did not improve overall survival or locoregional recurrence in …

… into the risk of locoregional recurrence after neoadjuvant … who did not receive regional
nodal irradiation, but it did not … risk of locoregional recurrence at 10 years for clinically node-…

… In this study, we compared the locoregional recurrence rate of patients with tumor-positive …
We analyzed the locoregional recurrence rate and found no differences in outcomes among …

… possibility on locoregional recurrence and … axillary lymph node dissection provides no
survival and oncological benefit compared with sentinel lymph node dissection ± further axillary …

… suffered from distant metastases and 32% were diagnosed no more than 3 months after
regional relapse. Molecular types did not differ significantly in locoregional recurrence with …

… breast-conservation surgery with a positive sentinel lymph node … After a median follow-up
of 51 months, we found that CLND did not correlate with changes in locoregional recurrence, …

… No completion axillary lymph node dissection was performed. The primary endpoint was …
Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection …

… locoregional recurrence, any invasive (locoregional and distant) recurrence, and the
number of lymph nodes … The 3-year cumulative incidence of axillary recurrence did not differ …

… We conclude that SLBx can be used safely in Z0011-eligible cohort without any increase
of the risk of locoregional recurrence. Also, we found omission of ALND is favored to reduce …

… The long-term results of the Z0011 clinical trial provided additional evidence and demonstrated
that complete axillary dissection is not necessary for prolonged locoregional control and …